Matches in Wikidata for { <http://www.wikidata.org/entity/Q66391360> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66391360 description "clinical trial" @default.
- Q66391360 description "ensayu clínicu" @default.
- Q66391360 description "klinisch onderzoek" @default.
- Q66391360 description "клінічне випробування" @default.
- Q66391360 name "A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke." @default.
- Q66391360 name "A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke." @default.
- Q66391360 type Item @default.
- Q66391360 label "A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke." @default.
- Q66391360 label "A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke." @default.
- Q66391360 prefLabel "A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke." @default.
- Q66391360 prefLabel "A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke." @default.
- Q66391360 P1050 Q66391360-3695F588-BC05-4413-B9E0-47FA6449B4AB @default.
- Q66391360 P1050 Q66391360-EBCFC995-2E9D-433C-80BD-0D8B79138803 @default.
- Q66391360 P1050 Q66391360-EEF7CF5C-3880-4DB3-AA7C-1AF6464001FE @default.
- Q66391360 P1132 Q66391360-EE183210-BAA2-4E3D-971F-D960CEC880DB @default.
- Q66391360 P1476 Q66391360-F4BDB5CB-E00F-4CA2-833D-F70EC4C1C303 @default.
- Q66391360 P2899 Q66391360-CCD681C7-EC34-4B8C-B3D4-C2D408A8FB58 @default.
- Q66391360 P3098 Q66391360-A8030E4B-9100-4DB2-9EED-75C3C9895B60 @default.
- Q66391360 P31 Q66391360-B1FECD84-FF20-495E-9473-71AC0A5076CD @default.
- Q66391360 P4135 Q66391360-E5BE149B-A89C-4E07-A0B6-79F5E23989B8 @default.
- Q66391360 P580 Q66391360-1087AB34-D6C6-4AEF-BBCC-3F2E2AB79511 @default.
- Q66391360 P582 Q66391360-AF1C46C2-D8A5-4233-95CF-59C51268DE6D @default.
- Q66391360 P6099 Q66391360-F19E5C92-FA0C-4229-98AB-BE4C427E0089 @default.
- Q66391360 P8363 Q66391360-D4657F90-A818-4E95-95B2-3571BE0300F3 @default.
- Q66391360 P1050 Q1209150 @default.
- Q66391360 P1050 Q12202 @default.
- Q66391360 P1050 Q188151 @default.
- Q66391360 P1132 "+180" @default.
- Q66391360 P1476 "A PhaseⅡ, Multicenter, Prospective Randomised, Open Blinded Endpoint Study to Evaluate Safety and Efficacy of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke." @default.
- Q66391360 P2899 "+18" @default.
- Q66391360 P3098 "NCT04028518" @default.
- Q66391360 P31 Q30612 @default.
- Q66391360 P4135 "+75" @default.
- Q66391360 P580 "2019-07-20T00:00:00Z" @default.
- Q66391360 P582 "2020-10-31T00:00:00Z" @default.
- Q66391360 P6099 Q42824440 @default.
- Q66391360 P8363 Q78089383 @default.